• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, April 13, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Lithuania joins the EMBO Installation Grants scheme

Bioengineer by Bioengineer
January 23, 2017
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

EMBO Programme Manager, Gerlind Wallon, explained, "EMBO Installation Grants encourage talented young group leaders to establish laboratories in countries which might otherwise lose their top scientists abroad. These grants also support the transfer of skills and knowledge from more established research communities to the participating countries. Lithuania is continuing to grow its international profile in the life sciences and we look forward to supporting the foundation of high-quality research groups there."

The EMBO Installation Grants scheme was launched in 2006 and currently offers grants to laboratories in the Czech Republic, Estonia, Poland, Portugal and Turkey, as well as Lithuania. Grants are targeted at scientists who wish to move to these countries and have spent at least two consecutive years working elsewhere.

Professor Virginijus Siksnys, Lithuania's representative at the European Molecular Biology Conference (EMBC), described the positive impact of joining the scheme. "It is a pleasure to see new opportunities for young researchers to establish research facilities in Lithuania," he stated. "The ability to compete with larger economies to attract the finest researchers will help the continued growth of life sciences in our country."

The latest call for applications to the EMBO Installation Grants scheme was made on 20th January 2017. Scientists intending to found new laboratories in one of the eligible countries are encouraged to apply via the EMBO website by 15th April 2017. For more details, see http://www.embo.org/funding-awards/installation-grants

###

About EMBO

EMBO is an organization of more than 1700 leading researchers that promotes excellence in the life sciences. The major goals of the organization are to support talented researchers at all stages of their careers, stimulate the exchange of scientific information, and help build a European research environment where scientists can achieve their best work.

EMBO helps young scientists to advance their research, promote their international reputations and ensure their mobility. Courses, workshops, conferences and scientific journals disseminate the latest research and offer training in techniques to maintain high standards of excellence in research practice. EMBO helps to shape science and research policy by seeking input and feedback from our community and by following closely the trends in science in Europe.

For more information: http://www.embo.org

About EMBC

The European Molecular Biology Conference (EMBC) is an intergovernmental organization comprising 29 member states. EMBC promotes a strong transnational approach to the life sciences. Within EMBC, member states pool their resources to improve the quality of research at a national level and to contribute to the advancement of basic research in Europe.

For more information: embc.embo.org

Media Contact

Tilmann Kiessling
[email protected]
49-160-901-93839
@EMBOcomm

http://www.embo.org

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

One-Step Bilayer Ethyl Cellulose Enables Full-Color Cooling

One-Step Bilayer Ethyl Cellulose Enables Full-Color Cooling

April 13, 2026

Africa’s Data Science Revolution: Health Impact Readiness

April 13, 2026

Green-Blue Adaptation Spurs Gentrification in African Cities

April 13, 2026

Intensive Control Transforms Malaria Genetics in Southeast Asia

April 13, 2026
Please login to join discussion

POPULAR NEWS

  • Scientists Investigate Possible Connection Between COVID-19 and Increased Lung Cancer Risk

    59 shares
    Share 24 Tweet 15
  • Boosting Breast Cancer Risk Prediction with Genetics

    47 shares
    Share 19 Tweet 12
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    45 shares
    Share 18 Tweet 11
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1012 shares
    Share 400 Tweet 250

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

One-Step Bilayer Ethyl Cellulose Enables Full-Color Cooling

Africa’s Data Science Revolution: Health Impact Readiness

Green-Blue Adaptation Spurs Gentrification in African Cities

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 79 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.